✣OncoGonFROM DISCOVERY TO IMPACT
HomeAssetsTriage & Prioritisation
3D Tumour IntelligenceExperimentsImagingSegmentation & QCResponse AnalysisAI Analysis (OSIEL)
Qualified AssetsIndustry & Data RoomCollaborationReports & Insights
Admin
Home3D Tumour IntelligenceLU-003
Loading study workspace…
3D Tumour Intelligence

LU-003

QC ReviewRESEARCH MODE

NSCLC PROTAC Response Study

AssetOGC-LU-104CancerLung CancerSubtypeNSCLCModel3D Tumour SpheroidLead ScientistDr. A. Kumar
Review DiscussionAsk OSIEL About This Study
Response values

Treatment Response

Drug B · Day 7 · All replicates

Viability18%
Tumour Size Change-71%
Relative Volume0.29
Growth Rate-0.14/day
Confidence0.92
Response ClassStrong Response

Quantitative results for interface validation. No scientific calculation is performed.

Illustrative 3D Visualisation

Stylised tumour response · not imaging-derived geometry

Drug B · Day 7
Illustrative visualisation

Growth / Response Over Time

Relative spheroid volume

Treatment Comparison

Day 7 viability and response class

Control96% viabilityGrowth
Drug A62% viabilityPartial Response
Drug B18% viabilityStrong Response

Replicate Variability

Drug B · viability by replicate

Replicate R3 requires QC confirmation before final interpretation.

Analysis Context

Methods and governance

Image-derived metrics are illustrative and require scientist review.

Response labels require scientific review, not a validated classification.

Protocol: OG-PROT-3D-021 · Result version: v1.2

Study Context

Current scientific record

StageQC Review
QCNeeds Review
ProtocolOG-PROT-3D-030
Images78
Last Updated2026-09-30

Current Attention

Research review queue

QC Review review pendingNeeds Review QC status requires confirmation
Research data · human review required.